Tobeka Daki was diagnosed with HER2 positive breast cancer in 2013. She needed a cancer drug made by Roche, trastuzumab. But it was too expensive and patents on the drug blocked the production of any affordable alternatives in South Africa where she lived. Photograph by MSF
Blog |
18 January 2021

Will history repeat itself?

INTELLECTUAL PROPERTY AND TRADE
Photograph by MSF
Tobeka Daki was diagnosed with HER2 positive breast cancer in 2013. She needed a cancer drug made by Roche, trastuzumab. But it was too expensive and patents on the drug blocked the production of any affordable alternatives in South Africa where she lived. Photograph by MSF

Why we need to learn from the HIV pandemic in rebutting pharma’s rejection of a global COVID-19 IP waiver by Felipe Carvalho, Yuanqiong Hu and Leena Menghaney

Continue Reading